Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(14 sites)

United States

Associated Retina Consultants, Phoenix, Arizona

California Retina Consultants, Bakersfield, California

Retina-Vitreous Associates Medical Group, Beverly Hills, California

Gavin Herbert Eye Institute, UC Irvine, Irvine, California

Retina Consultants Medical Group, Sacramento, California

Bay Area Retina Associates, Walnut Creek, California

Vitreo Retinal Associates, Gainesville, Florida

Georgia Retina, Marietta, Georgia

Illinois Retina Associates, Oak Park, Illinois

NJRetina, Teaneck, New Jersey

Long Island Vitreoretinal Consultants, Westbury, New York

Retina Consultants of Texas: Bellaire Retina Center, Bellaire, Texas

Retina Consultants of Texas: San Antonio, San Antonio, Texas

The Retina Group of Washington, Fairfax, Virginia